CpG-STAT3 siRNA CAS3/SS3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CpG-STAT3 siRNA CAS3/SS3, covering 2024-04-25 to 2024-04-25. Get the full timeline:
Most recent: Clinical Trial Update: CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL [Phase 1]